These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12503199)

  • 1. GSIs described as most important finding in cancer-targeting research.
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):617-8. PubMed ID: 12503199
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific enzyme identified that snips APP into beta-amyloid.
    Senior K
    Drug Discov Today; 2005 Nov; 10(21):1408. PubMed ID: 16243255
    [No Abstract]   [Full Text] [Related]  

  • 3. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
    Pollack SJ; Lewis H
    Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human beta-secretase (BACE) and BACE inhibitors.
    John V; Beck JP; Bienkowski MJ; Sinha S; Heinrikson RL
    J Med Chem; 2003 Oct; 46(22):4625-30. PubMed ID: 14561080
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedicine. Avoiding collateral damage in Alzheimer's disease treatment.
    Glabe C
    Science; 2006 Oct; 314(5799):602-3. PubMed ID: 17068248
    [No Abstract]   [Full Text] [Related]  

  • 6. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
    Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of gamma-secretase.
    Prasad CV; Vig S; Smith DW; Gao Q; Polson CT; Corsa JA; Guss VL; Loo A; Barten DM; Zheng M; Felsenstein KM; Roberts SB
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3535-8. PubMed ID: 15177468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Chemical Society--228th National Meeting. Gamma-secretase inhibitors. 22-26 August 2004, Philadelphia, PA, USA.
    Paterson D; Ognjenovic M
    IDrugs; 2004 Oct; 7(10):895-7. PubMed ID: 15478008
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core.
    Lewis SJ; Smith AL; Neduvelil JG; Stevenson GI; Lindon MJ; Jones AB; Shearman MS; Beher D; Clarke E; Best JD; Peachey JE; Harrison T; Castro JL
    Bioorg Med Chem Lett; 2005 Jan; 15(2):373-8. PubMed ID: 15603957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
    Jelley RA; Elliott J; Gibson KR; Harrison T; Beher D; Clarke EE; Lewis HD; Shearman M; Wrigley JD
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3839-42. PubMed ID: 16682202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
    Harrison T; Churcher I; Beher D
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH signaling as a novel cancer therapeutic target.
    Miele L; Miao H; Nickoloff BJ
    Curr Cancer Drug Targets; 2006 Jun; 6(4):313-23. PubMed ID: 16848722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secretases as therapeutic targets for the treatment of Alzheimer's disease].
    Dejaegere T; de Strooper B
    Verh K Acad Geneeskd Belg; 2004; 66(1):29-58; discussion 58-9. PubMed ID: 15074081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors.
    Asso V; Ghilardi E; Bertini S; Digiacomo M; Granchi C; Minutolo F; Rapposelli S; Bortolato A; Moro S; Macchia M
    ChemMedChem; 2008 Oct; 3(10):1530-4. PubMed ID: 18781572
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
    Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
    ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
    [No Abstract]   [Full Text] [Related]  

  • 16. Searching for the most effective screening system to identify cell-active inhibitors of beta-secretase.
    Middendorp O; Lüthi U; Hausch F; Barberis A
    Biol Chem; 2004 Jun; 385(6):481-5. PubMed ID: 15255179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH1 pathway: a molecular target in T-cell cancers?
    Holowiecki J
    Lancet; 2005 Jan 15-21; 365(9455):197-9. PubMed ID: 15652588
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of neutrophil apoptosis by beta-amyloid proteins.
    Park HY; Park JI; Baek DW; Lee SY; Lee MJ; Jin JO; Kim JW; Hong YS; Lee YH; Kwak JY
    Int Immunopharmacol; 2006 Jul; 6(7):1061-9. PubMed ID: 16714209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxytriamides as potent gamma-secretase inhibitors.
    Prasad CV; Wallace OB; Noonan JW; Sloan CP; Lau W; Vig S; Parker MF; Smith DW; Hansel SB; Polson CT; Barten DM; Felsenstein KM; Roberts SB
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1917-21. PubMed ID: 15050627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.